filmov
tv
Personalized treatment of advanced HER2-negative gastric or gastroesophageal junction cancer
Показать описание
Unmet needs, emerging therapies, and the importance of biomarker testing in HER2-negative GC/GEJC.
With insights provided by Dr Reetu Mukherji, Dr Jaffer Ajani and Dr Nataliya Uboha.
--------
This activity is funded by an independent medical education grant from Astellas Pharma Inc. and is jointly provided by USF Health and touchIME.
With insights provided by Dr Reetu Mukherji, Dr Jaffer Ajani and Dr Nataliya Uboha.
--------
This activity is funded by an independent medical education grant from Astellas Pharma Inc. and is jointly provided by USF Health and touchIME.
0:35:36
0:04:46
0:25:14
0:01:41
0:06:07
0:01:07
0:15:00
0:02:06
0:04:03
0:46:00
0:05:02
0:01:37
0:31:21
1:38:56
0:55:33
0:59:57
0:04:16
0:57:18
0:52:57
0:05:54
0:03:50
1:53:03
0:46:23
0:03:58